Role of the NADPH Oxidases in the Subfornical Organ in Angiotensin II–Induced Hypertension

• Published in: Hypertension (Dallas, Tex. 1979) Tex. 1979), 2013-02, Vol.61 (2), p.382-387
• Main Authors: Lob, Heinrich E, Schultz, David, Marvar, Paul J, Davisson, Robin L, Harrison, David G
• Format: Article
• Language: English
• Subjects: Angiotensin II; Animals; Arterial hypertension. Arterial hypotension; Biological and medical sciences; Blood and lymphatic vessels; Blood Pressure - physiology; Cardiology. Vascular system; Clinical manifestations. Epidemiology. Investigative techniques. Etiology; Hypertension - chemically induced; Hypertension - metabolism; Hypertension - physiopathology; Inflammation - metabolism; Inflammation - physiopathology; Integrases - genetics; Medical sciences; Mice; Mice, Transgenic; NADPH Oxidases - genetics; NADPH Oxidases - metabolism; Oxidation-Reduction; Protein Subunits - genetics; Reactive Oxygen Species - metabolism; Subfornical Organ - metabolism; Subfornical Organ - physiopathology
• ISSN: 0194-911X; 1524-4563
• DOI: 10.1161/HYPERTENSIONAHA.111.00546

Reactive oxygen species and the NADPH oxidases contribute to hypertension via mechanisms that remain undefined. Reactive oxygen species produced in the central nervous system have been proposed to promote sympathetic outflow, inflammation, and hypertension, but the contribution of the NADPH oxidases to these processes in chronic hypertension is uncertain. We therefore sought to identify how NADPH oxidases in the subfornical organ (SFO) of the brain regulate blood pressure and vascular inflammation during sustained hypertension. We produced mice with loxP sites flanking the coding region of the NADPH oxidase docking subunit p22. SFO-targeted injections of an adenovirus encoding cre-recombinase markedly diminished p22, Nox2, and Nox4 mRNA in the SFO, as compared with a control adenovirus encoding red-fluorescent protein injection. Increased superoxide production in the SFO by chronic angiotensin II infusion (490 ng/kg min ×2 weeks) was blunted in adenovirus encoding cre-recombinase–treated mice, as detected by dihydroethidium fluorescence. Deletion of p22 in the SFO eliminated the hypertensive response observed at 2 weeks of angiotensin II infusion compared with control adenovirus encoding red-fluorescent protein-treated mice (mean arterial pressures=97±15 versus 154±6 mm Hg, respectively; P=0.0001). Angiotensin II infusion also promoted marked vascular inflammation, as characterized by accumulation of activated T-cells and other leukocytes, and this was prevented by deletion of the SFO p22. These experiments definitively identify the NADPH oxidases in the SFO as a critical determinant of the blood pressure and vascular inflammatory responses to chronic angiotensin II, and further support a role of reactive oxygen species in central nervous system signaling in hypertension.